HEIDELBERG, Germany–Gene Bridges GmbH, the recombineering company, today announced that Chugai Pharmaceutical Co., Ltd. of Tokyo, Japan has completed the amendment to expand the commercial license agreement existing since 2005 for the use of the Red/ET recombination technology from Gene Bridges. The Red/ET recombination technology, patented in Japan under the title “Novel DNA Cloning Method“, […]
QIAamp kit sets new standard for the extraction of free circulating DNA and RNA fragments in human blood Venlo, The Netherlands, May 25, 2009 — QIAGEN today announced the launch of a novel product for extraction of free circulating fragments of tumor- and fetal-derived nucleic acids as well as viral nucleic acids in human blood. […]
Milligram quantities of highly purified Phospho-specific polyclonal antibodies are available from AMSBIO (www.amsbio.com) custom designed for optimal recognition of specific phosphorylation sites on the protein of interest to research scientists. Phosphorylation events are integral to cellular regulation functions including activation of enzymes and receptors, cellular transcription, signal transduction and cell signaling networks. Custom phospho-specific antibody […]
Industry Thought Leaders Edit Two Reference Books Essential for Advancing Regenerative Medicine CARLSBAD, Calif.–Invitrogen, a division of Life Technologies Corporation (NASDAQ:LIFE), today announced that four of its scientists whose work is focused in stem cell research are editors of two recently published books that capture many of the latest findings in this field and provide […]
MADISON, Wis.–The just released Promega GloMax®-Multi+ Detection System provides cross functionality with its ability to work in fluorescence, luminescence and absorbance read modes. With the GloMax-Multi+, scientists can easily multiplex their experiments and read luminescent and fluorescent cell-based assay data from the same microplate well. The benefits to scientists, in addition to multiplexing, include quality […]
Expanded Product Details, Enhanced Purchasing Capabilities Accelerate Research and Checkout CARLSBAD, Calif.–Invitrogen, a division of Life Technologies Corporation (NASDAQ:LIFE), today announced significant enhancements to its online store: www.invitrogen.com. These improvements simplify product selection and ordering, and further streamline laboratory workflows for users of the site, which is the top-rated online source for life science products. […]
PALO ALTO, Calif., May 19 — Varian, Inc. (NasdaqGS: VARI – News) announces the release of new StratoSpheres(TM) DNA Synthesis Cartridges. These cartridges enable high throughput synthesis of high quality oligonucleotides. Using automated instruments, small to medium sized oligonucleotides are synthesized in vast numbers across the world for use in DNA amplification, sequencing and hybridization. […]
WOBURN, MA–(May 19, 2009) – Mercury Therapeutics, a privately held biotech company based in Woburn, Massachusetts focusing on the development of AMP-activated protein kinase (AMPK) activators for the development of novel therapeutics for type 2 diabetes, oncology and cardiovascular disease, announced today the signing of a world wide exclusive license with Millipore Corp. of Bedford, […]
Depletion of albumin and IgG from human serum and plasma allows detection of less abundant proteins GE Healthcare announces the launch of HiTrap™ Albumin & IgG Depletion and Albumin & IgG Depletion SpinTrap™ prepacked columns, for the depletion of albumin and IgG from human serum and plasma. Depleting samples of albumin and IgG allows proteins […]
CalBioreagents has announced the release of 2 NEW Monoclonal Antibodies for Hemoglobin A1c (HbA1c). HbA1c is an accepted marker for the measure of long-term glycemic control in diabetes. The growing epidemic of diabetes has led to the proposal that HbA1c be measured to monitor continuing therapy in diabetes patients, and that HbA1c be used as […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
